Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Medtronic drops as full-year outlook trails analyst views

Published 05/25/2023, 08:41 AM
© Reuters.  Medtronic (MDT) drops as full-year outlook trails analyst views
MDT
-

Medtronic (NYSE:MDT) shares dipped in premarket Thursday after the medical device company delivered softer-than-expected guidance.

Medtronic posted adjusted EPS of $1.57 on revenue of $8.54 billion. Analysts were looking for earnings of $1.55 on revenue of $8.25B. The outperformance was driven by the Cardiovascular segment, which saw its sales jump 12% year-over-year.

Medtronic shares are down 3.9% in premarket.

"Our accelerating revenue growth was broad-based, driven by procedure volume recovery, supply improvements, and innovative product introductions," said Geoff Martha, Medtronic chairman and chief executive officer.

For FY24, Medtronic sees adjusted EPS at $5.05, below the $5.28 expected. Organic revenue is seen rising 4-4.5% YoY.

The company also said it will acquire wearable insulin patch maker EOFlow.

Deutsche Bank analysts commented:

“Relative to other medtech companies reporting blow-out 1Q revenue results, the 85 bps of organic revenue beat seems a bit disappointing and we wonder if: (1) MDT’s core markets simply didn’t recover as much as other companies; (2) April slowed down. Bulls will point to MDT’s February – April reporting period, hence MDT didn’t have the easy January comps that the others had.”

Stifel analysts weighed in more positively on MDT.

“Stock could react negatively today. But with an improving macro backdrop, key diabetes business approvals achieved, and low growth first half comps, Medtronic could potentially be set up for a meet and exceed F2024 year,” they said.

 
 
 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.